Product Information

TADALAFIL 5 MG TABLET is a generic product labeled by Solco Healthcare US LLC, priced at $0.1134 per EA under NDC 43547003103. Its NADAC has been published 76 times since Jun 11, 2025.

FDA first approved this application on Aug 11, 2022. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TADALAFIL 5 MG TABLET

tadalafil
$0.1134per EA

Strength

5 mg/1

NDC

43547003103

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

TADALAFIL

Approval Type

Generic (ANDA)

FDA Application

ANDA210609

FDA Approved

8/11/2022

TE Code

AB1

On Market Since

11/27/2024

Pharmacological Classes

Phosphodiesterase 5 Inhibitor
Phosphodiesterase 5 Inhibitors

Price Statistics

The NADAC for TADALAFIL 5 MG TABLET has been published 76 times since Jun 11, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$0.1134 per EA
All-time high$0.1231 (Oct 15, 2025)
All-time low$0.1014 (Jul 22, 2026)
52-week high$0.1162
52-week low$0.1014
Median price$0.1076
Average price$0.1095
Largest weekly change+6.9% (Aug 20, 2025)
Weeks tracked76
Tracking sinceJun 11, 2025

Price History

1W

+5.3%

1M

+9.9%

3M

+11.0%

6M

+7.8%

1Y

-7.6%

3Y

N/A

5Y

N/A

All

+1.7%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TADALAFIL 5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for TADALAFIL 5 MG TABLET, manufactured by Solco Healthcare US LLC, is $0.1134 per EA (NDC 43547003103), effective Nov 18, 2026.

How has the price of TADALAFIL 5 MG TABLET changed over time?

Over the history we have for it, the NADAC for TADALAFIL 5 MG TABLET has held within roughly two percent of its current level. It has been tracked across 76 weekly CMS publications since Jun 11, 2025.

What are the highest and lowest recorded NADAC prices for TADALAFIL 5 MG TABLET?

Since Jun 11, 2025, the NADAC for TADALAFIL 5 MG TABLET has ranged from a low of $0.1014 (Jul 22, 2026) to a high of $0.1231 (Oct 15, 2025), with a median of $0.1076 per EA.

Are there cheaper alternatives to TADALAFIL 5 MG TABLET?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TADALAFIL 5 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures TADALAFIL 5 MG TABLET?

TADALAFIL 5 MG TABLET (NDC 43547003103) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.